Books on the topic 'Heparin'

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. 4th ed. New York: Informa Healthcare USA, 2007.

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. 3rd ed. New York: Marcel Dekker, 2004.

Warkentin, Theodore E., and Andreas Greinacher. Heparin-induced thrombocytopenia. 4th ed. New York: Informa Healthcare, 2007.

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. New York: Dekker, 2000.

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. 2nd ed. New York: Dekker, 2001.

Lane, David A., Ingemar Björk, and Ulf Lindahl, eds. Heparin and Related Polysaccharides. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4899-2444-5.

1949-, Lane D. A., Björk Ingemar, and Lindahl Ulf 1939-, eds. Heparin and related polysaccharides. New York: Plenum Press, 1992.

Barrowcliffe, Trevor W. Low molecular weight heparin. Chichester, West Sussex, England: Wiley, 1992.

Chang, Shau-Feng. Studies on structure, heparin-binding, and gene expression of hepatic lipase. München: Dissertationsverlag NG Kopierladen, 1993.

institutet, Karolinska, ed. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity: Effects of heparin and a low molecular weight heparin fragment (Fragmin®). Stockholm: Acta medica Scandinavica, 1988.

Lever, Rebecca, Barbara Mulloy, and Clive P. Page, eds. Heparin - A Century of Progress. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-23056-1.

1949-, Machin Samuel J., ed. Heparin: Actions, indications & clinical experience. London: Mediq, 1988.

Lantbruksuniversitet, Sveriges, ed. Why does Heparin bind antithrombin? Uppsala: Sveriges Lantbruksuniversitet, 1988.

A, Lane David, and Lindahl Ulf, eds. Heparin: Chemical and biological properties, clinical applications. London: Arnold, 1989.

Holmer, Erik. Heparin and its low molecular weight derivatives: Basic and applied studies in the development of a new antithrombotic drug. Uppsala: Sveriges Lantbruksuniversitet, 1987.

Maccarana, Marco. O-sulfate groups in heparin and heparan sulfate: Formation and roles in protein building. Uppsala: University of Uppsala, 1994.

Westman, Jacob. Synthesis of oligosaccharides related to heparin and heparan sulphate and their binding to fibroblast growth factors. Stockholm, Sweden: Dept. of Organic Chemistry, Arrhenius Laboratory, Stockholm University, 1995.

Neisius, Petra. Niedermolekulares Heparin und Standard-Heparin im klinischen Vergleich: Eine Untersuchung zur Wirksamkeit, Verträglichkeit und laborchemischen Kontrolle der Low-dose-Heparin-Prophylaxe thrombembolischer Komplikationen in der Chirurgie. [s.l.]: [s.n.], 1988.

Hyers, Thomas M. Treatment handbook of low-molecular-weight heparin. London: Science Press, 2000.

Kimmerle, Inge. Untersuchungen zur enzymatischen Inaktivierung des Gerinnungshemmers Heparin. Hohenheim: [s.n.], 1986.

1949-, Lane D. A., and Lindahl Ulf 1939-, eds. Heparin: Chemical and biological properties, clinical applications. Boca Raton, Fla: CRC Press, 1989.

Khaliq, Yasmin. Clinical significance of the nitroglycerin-heparin interaction. [Ottawa, Ont.?: s.n.], 1991.

A, Ofosu Frederick, Danishefsky Isidore, Hirsh Jack 1935-, and New York Academy of Sciences., eds. Heparin and related polysaccharides: Structure and activities. New York, N.Y: New York Academy of Sciences, 1989.

Lantbruksuniversitet, Sveriges, ed. Formation and degradation of the Heparin proteoglycan. Uppsala: Sveriges Lantbruksuniversitet, 1986.

Maguire, Jacinta Marie. Low molecular weight heparin regime or unfractionated heparin and as pirin in the treatment of unstable angina. [S.l: The Author], 1994.

Ettelaie, Cammile. Interaction of Heparin with antithombin III and polycations. Salford: University of Salford, 1987.

Tierney, David Patrick. The fractionation and characterisation of commercial heparin preparations. Salford: University of Salford, 1986.

1968-, Oremus Mark, United States. Agency for Healthcare Research and Quality., and McMaster University. Evidence-based Practice Center., eds. The uses of heparin to treat burn injury. Rockville, MD: AHRQ, 2006.

Lidholt, Kerstin. A new model for the biosynthesis of heparin. Uppsala: Swedish University of Agricultural Sciences, Faculty of Veterinary Medical Chemistry, Dept. of Veterinary Medical Chemistry, 1991.

Sharma, Anupama. A comparison of the binding abilities of human kidney heparan sulphate and heparin glycosaminoglycans for antithrombin III. Manchester: University of Manchester, 1995.

Kovaliv, Bohdan. Heparyn i heparynoïdy y klinichniĭ praktyt͡s︡i. Lʹviv: Lʹvivsʹkyĭ derz͡h︡avnyĭ medychnyĭ universytet im. Danyla Halyt͡s︡koho, 2003.

Nimmerfall, Katja. Die Wirkung von Heparin auf die Thrombozytenfunktion beim Hund. Hannover: [s.n.], 1999.

Grootjans, Jan Johann. Cytoplasmic interactions of the syndecans. Leuven: Leuven University Press, 2000.

International Fraxiparine Symposium (1st 1987 Paris, France). Fraxiparine: First international symposium : analytical and structural data, pharmacology, clinical trials. Edited by Fareed Jawed, Samama Meyer M, and Breddin K. 1928-. Stuttgart: Schattauer, 1989.

(Editor), Hari G. Garg, Robert J. Linhardt (Editor), and Charles A. Hales (Editor), eds. Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier Science, 2005.

Garg, Hari G., Charles A. Hales, and Robert J. Linhardt. Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier Science & Technology Books, 2011.

Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier, 2005. http://dx.doi.org/10.1016/b978-0-08-044859-6.x5000-x.

(Editor), Hari G. Garg, Robert J. Linhardt (Editor), and Charles A. Hales (Editor), eds. Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier Science, 2005.

Richer, Monique. Monitoring heparin therapy with the heparin assay. 1989.

Greinacher, Andreas, and Theodore Warkentin. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2003.

Warkentin, Theodore, ed. Heparin-Induced Thrombocytopenia. Informa Healthcare, 2003. http://dx.doi.org/10.1201/9780203027363.

Warkentin, Theodore. Heparin-Induced Thrombocytopenia. CRC Press, 2003. http://dx.doi.org/10.1201/9780824758844.

Warkentin, Theodore E., and Andreas Greinacher, eds. Heparin-Induced Thrombocytopenia. CRC Press, 2007. http://dx.doi.org/10.1201/b21615.

Heparin-Binding Proteins. Elsevier, 1998. http://dx.doi.org/10.1016/b978-0-12-186060-8.x5000-1.

Warkentin, Theodore E., and Andreas Greinacher, eds. Heparin-Induced Thrombocytopenia. CRC Press, 2007. http://dx.doi.org/10.3109/9781420045093.

Heparin-Induced Thrombocytopenia. CRC Press LLC, 2003.

Heparin-binding proteins. San Diego: Academic Press, 1998.

Warkentin, Theodore E. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2003.

Greinacher, Andreas, and Theodore Warkentin. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2012.

Greinacher, Andreas, and Theodore Warkentin. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2001.